• Carfilzomib: From Proteasome Blockade to Translation

  2026-08-28

  Carfilzomib (PR-171) offers translational researchers a mechanistically precise way to interrogate irreversible proteasome inhibition, proteotoxic stress, apoptosis, and rational combination strategies in cancer models.

• T7 RNA Polymerase for RNA Research Workflows

  2026-08-28

  Build reproducible RNA workflows for probes, functional transcripts, RNAi experiments, and RNA vaccine production with promoter-specific transcription. This guide connects practical template design and reaction optimization with assay choices inspired by a colorectal cancer study of DDX21, SIRT7, NAT10, and ac4C RNA modification.

• Toremifene Workflows for Prostate Cancer Research

  2026-08-27

  Toremifene provides a concentration-controlled way to interrogate estrogen receptor biology alongside metastatic signaling in prostate cancer models. This practical guide connects an in vitro cell growth inhibition assay with calcium, migration, protein-stability, and combination workflows while emphasizing controls, storage, and interpretation limits.

• SB203580: Mechanism, Benchmarks, and Workflow

  2026-08-27

  SB203580 is an ATP-competitive, selective p38 MAPK inhibitor used to dissect stress and inflammatory signaling. Its reported p38 MAPK potency is 0.3–0.5 μM, but the compound does not by itself establish a p38 mechanism in the cited nanoplastic vascular study, which examined ERK signaling.

• Moxidectin’s Antifungal Potential Beyond Deworming

  2026-08-26

  Moxidectin is moving from an established macrocyclic lactone anthelmintic into an emerging antifungal combination strategy. New evidence shows that it elevates Candida albicans ergosterol and potentiates polyenes, creating a translational opportunity that still requires rigorous mechanistic, formulation, safety, and resistance studies.

• Affordable GRO-seq in Bread Wheat: Study Insights

  2026-08-26

  This STAR Protocols study presents a cost-conscious GRO-seq workflow for profiling nascent transcription in allohexaploid bread wheat. Its central innovation is rRNA depletion after nuclear RNA isolation and before nascent RNA immunoprecipitation, which increased the proportion of valid data by 20-fold and improved enhancer-transcription analysis in a complex plant genome.

• Epoxomicin: A Causal Probe of RIPK3 Degradation

  2026-08-25

  Epoxomicin is a selective, irreversible proteasome inhibitor that can turn proteasome-dependent RIPK3 loss into a testable mechanistic hypothesis. This article translates viral inflammation findings into practical assay design, controls, interpretation rules, and reproducible handling guidance.

• PERK Loss Promotes Ferroptosis in Colorectal Cancer

  2026-08-25

  The reference study identifies PERK as a negative regulator of ferroptosis in colorectal cancer by linking PERK–ATF4 signaling to SLC7A11 expression. Its findings suggest that suppressing this stress-adaptation pathway can increase lipid peroxidation and restrict tumor growth, providing a mechanistic framework for apoptosis-resistant cancer models.

• N-octanoyl-L-Homoserine Lactone (C8-HSL)

  2026-08-24

  N-octanoyl-L-Homoserine lactone, also called C8-HSL, is a diffusible bacterial quorum-sensing molecule that can regulate LuxR-type transcriptional responses. Recent evidence also links C8-HSL exposure to PI3K/AKT/ERK-dependent proliferation, migration, and invasion of H460 lung cancer cells, while product specifications support controlled microbiology and infection biology research.

• Blebbistatin for Causal Cell Mechanics Imaging

  2026-08-24

  Blebbistatin enables reversible interrogation of non-muscle myosin II in migration, adhesion, and morphology assays. This guide shows how to combine the perturbation with structure–function imaging principles from panoramic cardiac mapping for stronger causal interpretation.

• NAT1–ENO1–Lactate Signaling in Colorectal Cancer

  2026-08-23

  This MedComm study identifies a NAT1–ENO1–lactate pathway that links tumor glycolysis to TRAF6-dependent PD-L1 stabilization and immune escape in colorectal cancer. Its combination of multi-omics, mechanistic protein analysis, patient-associated data, and mouse immunotherapy models suggests that disrupting lactate signaling may improve checkpoint blockade, while also defining practical endpoints for metabolic–immune studies.

• N-octanoyl-L-Homoserine lactone in Cell Assays

  2026-08-22

  Learn how N-octanoyl-L-Homoserine lactone (SKU C3579) can improve the design and interpretation of quorum-sensing, infection biology, and host-cell viability experiments. This scenario-based guide covers formulation, controls, assay compatibility, dose optimization, and vendor-selection considerations.

• Sodium Nitroprusside in Sex-Specific Vascular Research

  2026-08-22

  Sodium Nitroprusside provides a practical nitric oxide donor tool for separating vascular smooth muscle, platelet, and autonomic components of hypertension. Used alongside telemetry and isolated-vessel assays, it can turn sex-dependent blood-pressure phenotypes into testable mechanisms rather than descriptive observations.

• IGF2BP1–TUBB4B Signaling in Liver Fibrosis

  2026-08-21

  The reference study identifies an m6A-dependent IGF2BP1–TUBB4B–FAK pathway that promotes hepatic stellate cell activation, proliferation, and migration. Its combination of transcriptomic re-analysis, RNA-binding and m6A profiling, genetic perturbation, and pharmacological validation provides a useful framework for dissecting methylation-linked mechanisms in liver fibrosis.

• Acifran: From Receptor Structure to Assay Design

  2026-08-20

  Acifran is a structurally resolved HCAR2/HCAR3 agonist for lipid metabolism research. This guide translates cryo-EM findings into practical choices for receptor, cAMP, selectivity, and compound-handling assays.

474 records 1/32 page Next 12345 下5页 Last page